| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |